Mclaughlin Research Institute For Biomedical Sciences, operating under the name Mclaughlin Research Institute, is located in Great Falls, MT. The organization was established in 1994. According to its NTEE Classification (H92) the organization is classified as: Biomedicine & Bioengineering Research, under the broad grouping of Medical Research and related organizations. As of 06/2020, Mclaughlin Research Institute employed 23 individuals. This organization is an itermediate organization (such as a geographic headquarters) for a national or regional group of organizations. Mclaughlin Research Institute is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 06/2020, Mclaughlin Research Institute generated $2.9m in total revenue. The organization has seen a slow decline revenue. Over the past 5 years, revenues have fallen by an average of (0.3%) each year. All expenses for the organization totaled $2.1m during the year ending 06/2020. As we would expect to see with falling revenues, expenses have declined by (4.2%) per year over the past 5 years. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2020
Describe the Organization's Mission:
Part 3 - Line 1
THE INSTITUTE'S MISSION IS TO IMPROVE HUMAN HEALTH THROUGH INNOVATIVE GENETIC RESEARCH AND EDUCATION.
Describe the Organization's Program Activity:
Part 3 - Line 4a
DURING FISCAL YEAR 2020, THE INSTITUTE SCIENTISTS AND STAFF CONTINUED TO WORK TOWARD TRANSLATING RESEARCH ON NEURODEGENERATIVE DISEASES INTO TREATMENT DEVELOPMENT AND DISEASE PREVENTION. SUCH WORK INCLUDED PARTNERSHIPS WITH UP TO TEN COLLABORATORS AND 23 PROJECTS. EFFORTS CONTINUED TOWARDS UNDERTANDING HUNTINGTON'S DISEASE IN COLLABORATION WITH INVESTIGATORS FROM WESTERN WASHINGTON UNIVERSITY AND THE CURE HUNTINGTON'S DISEASE FOUNDATION, WAKE FOREST UNIVERSITY, THE UNIVERSITY OF CALIFORNIA SAN FRANCISCO, MONTANA STATE UNIVERSITY, AND COLUMBIA UNIVERSITY. THE INSTITUTE WAS WELL POSITIONED TO ACT AS A CRITICAL COMPONENT BRINGING PROMISING COMPOUNDS INTO CLINICAL TRIALS WITH SEVERAL PHARMACEUTICAL COMPANIES AND A PRIVATE FOUNDATION COLLABORATING TO SCREEN DEVELOPING THERAPEUTICS FOR SAFETY AND EFFICACY. THE INSTITUTE CONTINUED THE EFFORTS OF THE NIH FUNDED GRANT (AWARDED MARCH 2018) IN THE AMOUNT OF $405,000/YEAR FOR FIVE YEARS ($2 MILLION TOTAL) STUDYING NEUROTRANSMITTERS IN NEURODEGENERATIVE DISEASE. ADDITIONALLY, THE INSTITUTE PRODUCED LABORATORY ANIMALS AND COMPLETED PROCEDURES FOR THREE SUB-AWARDS TOTALING CLOSE TO $86,000; MULTIPLE SUB-CONTRACTS AT OVER $180,000; AND OTHER CONTRACTS FOR $530,000. AS A RESULT OF CONTINUED COMMUNITY OUTREACH THROUGHOUT GREAT FALLS AND GREATER MONTANA, CONTRIBUTIONS TOTALING 1.36 MILLION WERE RECEIVED BY THE INSTITUTE.
THE INSTITUTE CONTINUED EDUCATION PROVIDING SCHOLARSHIPS FOR SUMMER INTERNSHIPS TO TWO STUDENTS HOSTED AT THE INSTITUTE. STUDENTS LEARNED FIRSTHAND LABORATORY TECHNIQUES, EXPERIMENTAL DESIGN, AND DATA ANALYSIS WHILE WORKING DIRECTLY WITH INVESTIGATORS AND RESEARCH STAFF. STUDENT LEAD PRESENTATIONS HIGHLIGHTED THE LEARNING AND GROWTH OF INTERNS OVER THE INTERNSHIP TO FAMILY MEMBERS, STAFF AND BOARD MEMBERS, AS WELL AS THE GREATER GREAT FALLS COMMUNITY.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Teresa Gunn Associate Professor | 40 | $114,964 | |
Michael Kavanaugh PHD Director | Officer | 20 | $92,550 |
Jenessa Nitschke Fin & Res Sup Officer | Officer | 40 | $78,783 |
Maxon Davis Vice-President | OfficerTrustee | 1 | $0 |
John Lane Secretary | OfficerTrustee | 1 | $0 |
Randy Gray Chair | OfficerTrustee | 5 | $0 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $0 |
Fundraising events | $0 |
Related organizations | $0 |
Government grants | $429,513 |
All other contributions, gifts, grants, and similar amounts not included above | $1,656,863 |
Noncash contributions included in lines 1a–1f | $0 |
Total Revenue from Contributions, Gifts, Grants & Similar | $2,086,376 |
Total Program Service Revenue | $293,061 |
Investment income | $102,944 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | $394,852 |
Net Income from Fundraising Events | $0 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $2,881,556 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $0 |
Grants and other assistance to domestic individuals. | $6,500 |
Grants and other assistance to Foreign Orgs/Individuals | $0 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $164,511 |
Compensation of current officers, directors, key employees. | $85,767 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $623,897 |
Pension plan accruals and contributions | $74,979 |
Other employee benefits | $353,823 |
Payroll taxes | $67,782 |
Fees for services: Management | $0 |
Fees for services: Legal | $0 |
Fees for services: Accounting | $1,875 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $28,097 |
Fees for services: Other | $60,849 |
Advertising and promotion | $0 |
Office expenses | $1,037 |
Information technology | $35,137 |
Royalties | $0 |
Occupancy | $217,774 |
Travel | $473 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $31 |
Interest | $2,818 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $406,082 |
Insurance | $32,945 |
All other expenses | -$444,925 |
Total functional expenses | $2,129,940 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $1,196,473 |
Savings and temporary cash investments | $0 |
Pledges and grants receivable | $19,250 |
Accounts receivable, net | $27,079 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $15,972 |
Prepaid expenses and deferred charges | $47,288 |
Net Land, buildings, and equipment | $6,151,999 |
Investments—publicly traded securities | $3,488,226 |
Investments—other securities | $62,460 |
Investments—program-related | $0 |
Intangible assets | $0 |
Other assets | $1,618 |
Total assets | $11,010,365 |
Accounts payable and accrued expenses | $32,399 |
Grants payable | $0 |
Deferred revenue | $8,633 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $73,583 |
Unsecured mortgages and notes payable | $127 |
Other liabilities | $390,775 |
Total liabilities | $505,517 |
Net assets without donor restrictions | $7,042,597 |
Net assets with donor restrictions | $3,462,251 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $0 |
Total liabilities and net assets/fund balances | $11,010,365 |
Over the last fiscal year, we have identified 3 grants that Mclaughlin Research Institute For Biomedical Sciences has recieved totaling $5,012,029.
Awarding Organization | Amount |
---|---|
Schwab Charitable Fund San Francisco, CA PURPOSE: HEALTH | $5,002,000 |
The Carter Chapman Shreve Family Foundation Wilmington, DE PURPOSE: GENERAL & UNRESTRICTED | $10,000 |
Amazonsmile Foundation Seattle, WA PURPOSE: GENERAL SUPPORT | $29 |
Beg. Balance | $3,522,643 |
Earnings | -$63,752 |
Admin Expense | $25,593 |
Other Expense | $188,578 |
Ending Balance | $3,244,720 |
Organization Name | Assets | Revenue |
---|---|---|
Infectious Disease Research Institute Seattle, WA | $13,563,097 | $13,342,560 |
University Medical Group Inc Portland, OR | $0 | $19,037,411 |
Seattle Institute For Biomedical And Clinical Research Seattle, WA | $15,332,692 | $17,750,569 |
Steadman Philippon Research Institute Vail, CO | $14,955,351 | $15,214,073 |
Washington Research Foundation Seattle, WA | $325,923,396 | $51,887,435 |
The Young Living Foundation Lehi, UT | $9,856,727 | $9,672,215 |
Colorado Prevention Center Aurora, CO | $19,075,363 | $15,993,766 |
Minneapolis Heart Institute Foundation Minneapolis, MN | $51,520,170 | $19,174,876 |
Cancer Research And Biostatistics Seattle, WA | $8,442,496 | $11,626,712 |
Research Development Foundation Carson City, NV | $46,239,131 | $15,306,815 |
Essentia Institute Of Rural Health Duluth, MN | $6,914,650 | $9,904,383 |
Pacific Northwest Research Institute Seattle, WA | $26,418,293 | $6,927,038 |